AGL vs PATH · rev $6.06B vs P/E 19, rev $1.61B
agilon health Inc (AGL) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
agilon health Inc (AGL) is a medical care facilities company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported AGL revenue for 2024-12-31 was $6.06B. Net income was -$260.1M. Revenue was up 40.4% from 2023-12-31 to 2024-12-31. AGL currently screens at market cap $1.45B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
AGL currently screens at market cap $1.45B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the AGL and PATH stock pages for the full models.
Not investment advice.